Celldex Therapeutics’ $230.5 Million Common Stock Offering

Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters.Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the public…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now